Groowe Groowe / Newsroom / NRXP
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NRXP News

NRX Pharmaceuticals, Inc. Common Stock

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application

globenewswire.com
NRXP

Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered “Depression Thermometer” Across its Interventional Psychiatry Network

globenewswire.com
NRXP

New to The Street Broadcasts Show #740 on Bloomberg Television at 6:30 PM EST Featuring Medicus (MDCX), Acme Markets- Canton Foundation, Alpha Ton Capital (ATON), and Virtuix Holdings (NASDAQ:VTIX)

accessnewswire.com
ACXP DVLT IGC NRXP SNYR TRN VTIX VVOS YYGH MDCX ATON

Form 8-K

sec.gov
NRXPW NRXP

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress

globenewswire.com
NRXP

New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST

accessnewswire.com
CAST LTRN VRTX NRXP DVLT RDZN SDST CISO

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026

globenewswire.com
NRXP

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application

globenewswire.com
NRXP

NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

globenewswire.com
NRXP

New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST

accessnewswire.com
SAGT MDCX YYGH NRXP SNYR SDST DVLT